Carmelo A. Milano

Chronic counterpulsation devices for heart failure.

Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice.

Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation.

Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients.

Paroxysmal cold hemoglobinuria and cardiopulmonary bypass.

Mechanical ventricular support lowers pulmonary vascular resistance in a patient with congential heart disease.

Differential gene expression and genomic patient stratification following left ventricular assist device support.

BVS5000 support after cardiac transplantation.

Gene therapy in cardiovascular disease: state of the art.

Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.

Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.

Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG.

Gene expression phenotypes of atherosclerosis.

Predictors of inotrope use during separation from cardiopulmonary bypass.

HeartMate XVE malfunction caused by fluid aspiration into the vent port.

Dose dependent effects of cardiac beta2 adrenoceptor gene therapy.

beta2 adrenoceptor gene therapy ameliorates left ventricular dysfunction following cardiac surgery.

Breast necrosis following use of the internal mammary artery for coronary artery bypass.

Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery.

Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.

Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy.

Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting.

Risk-adjusted short- and long-term outcomes for on-pump versus off-pump coronary artery bypass surgery.

Isolated mitral valve repair in patients with depressed left ventricular function.

Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.

A new anatomic score for prognosis after cardiac catheterization in patients with previous bypass surgery.

Outcomes with an alternate list strategy for heart transplantation.

A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.

Cardiac transplantation following ACORN CorCap device implantation.

Cardiac transplantation at Duke University Medical Center.

Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.

Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading.

Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.

Does a pre-left ventricular assist device screening score predict long-term transplantation success? A 2-center analysis.

Left ventricular endocardial irregularity: evaluation using epicardial echocardiography.

Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Histopathology and transmurality of acute microwave lesions on the beating human atrium.

Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.

Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States.

Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting.

Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure.

Malpositioned left ventricular assist device cannula: diagnosis and management with transesophageal echocardiography guidance.

Deterioration of regional wall motion immediately after coronary artery bypass graft surgery is associated with long-term major adverse cardiac events.

Survival prognosis and surgical management of ischemic mitral regurgitation.

Infectious complications in extended criteria heart transplantation.

Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries.

A previously unreported complication of apicoaortic conduit for severe aortic stenosis.

Laser-assisted extraction of pacemaker and defibrillator leads: the role of the cardiac surgeon.

INTERMACS: interval analysis of registry data.

Two-stage total cardioaortic replacement for end-stage heart and aortic disease in Marfan syndrome: case report and review of the literature.

Mortality trends associated with acute renal failure requiring dialysis after CABG surgery in the United States.

Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures.

Mitral gradients and frequency of recurrence of mitral regurgitation after ring annuloplasty for ischemic mitral regurgitation.

Surgical treatments for advanced heart failure.

Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.

Trends in cardiac surgery-associated acute renal failure in the United States: a disproportionate increase after heart transplantation.

Impact of left ventricular assist device bridging on posttransplant outcomes.

Advanced heart failure treated with continuous-flow left ventricular assist device.

Mitral valve repair for degenerative disease: a 20-year experience.

Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia.

Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.

Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury.

Left ventricular assist device destination therapy versus extended criteria cardiac transplant.

Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

An innovative approach for sternal closure.

Storage age of transfused platelets and outcomes after cardiac surgery.

The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants.

Reproducibility of left atrial ablation with high-intensity focused ultrasound energy in a calf model.

Influence of patient age on procedural selection in mitral valve surgery.

Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface.

Stress and coping in caregivers of patients awaiting solid organ transplantation.

Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices.

Effects of left ventricular assist device support on biomarkers of cardiovascular stress, fibrosis, fluid homeostasis, inflammation, and renal injury.

Presentation and management of left ventricular assist device inflow cannula malposition.

Utility of a simple algorithm to grade diastolic dysfunction and predict outcome after coronary artery bypass graft surgery.

Clinical trials in mechanical circulatory support.

Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation.

Recurrence of heart failure symptoms after LVAD placement due to bradycardia-induced inflow obstruction.

Replacement of continuous-flow left ventricular assist device via left subcostal incision.

Surgical treatment of a cavernous haemangioma of the heart.

Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy.

X-Linked Inhibitor of Apoptosis Protein-Mediated Attenuation of Apoptosis, Using a Novel Cardiac-Enhanced Adeno-Associated Viral Vector.

Mechanical circulatory support: devices, outcomes and complications.

Pilot study of sternal plating for primary closure of the sternum in cardiac surgical patients.

Increasing mitral valve repair rates with nonresectional techniques.

Three-dimensional transesophageal echocardiography for perioperative right ventricular assessment.

When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.

Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device.

Ramping up evidence-based ventricular assist device care.

Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality.

Gene therapy for the prevention of vein graft disease.

Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.

Endovascular stent grafting of a left ventricular assist device outflow graft pseudoaneurysm.

Twenty-five-year outcomes after multiple internal thoracic artery bypass.

Dysphagia in the setting of left ventricular assist device hemolysis.

Surgical correction of aortic valve insufficiency after left ventricular assist device implantation.

Impact of donor cardiac arrest on heart transplantation.

Ten-year experience with extended criteria cardiac transplantation.

Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery.

A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's disease.

Current readings: Surgical management of heart failure.

Outcomes after implantable left ventricular assist device replacement procedures.

Unexpected abrupt increase in left ventricular assist device thrombosis.

Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.

Minithoracotomy versus sternotomy for mitral surgery in patients with chronic renal impairment: a propensity-matched study.

Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices.

Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.

Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.

Valvular heart disease in patients supported with left ventricular assist devices.

Temporary extracorporeal left ventricular assist device support for implantable left ventricular assist device replacement cases.

Trends in the use and outcomes of ventricular assist devices among medicare beneficiaries, 2006 through 2011.

Risk-adjusted survival after tissue versus mechanical aortic valve replacement: a 23-year assessment.

Neurological complications of cardiac surgery.

Surgical Revascularization is Associated with Maximal Survival in Patients with Ischemic Mitral Regurgitation: A 20-Year Experience.

The Incidence, Risk, and Consequences of Atrial Arrhythmias in Patients with Continuous-Flow Left Ventricular Assist Devices.

Aortic valve replacement via right minithoracotomy versus median sternotomy: a propensity score analysis.

Transcatheter Aortic Valve Replacement Performed via Left Ventricular Assist Device Inflow Cannula.

Cardiac Implantable Electronic Device Removal in Patients with Left Ventricular Assist Device Associated Infections.

ABO blood group influences transfusion and survival after cardiac surgery.

Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices.

Central venous pressure after coronary artery bypass surgery: does it predict postoperative mortality or renal failure?

Phosphoproteomic profiling of human myocardial tissues distinguishes ischemic from non-ischemic end stage heart failure.

Characteristics and outcomes of patients with heart failure and discordant findings by right-sided heart catheterization and cardiopulmonary exercise testing.

Improved early survival with a nonsternotomy approach for continuous-flow left ventricular assist device replacement.

VAD therapy 20/20: moving beyond the myopic view of a nascent therapy.

Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow-up from the STICH trial.

Response to letter regarding article, "surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience".

Initial Experience of Left Ventricular Assist Device Support for Adult Patients with Transposition of the Great Vessels.

Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci.

Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow.

Right Minithoracotomy Versus Median Sternotomy for Mitral Valve Surgery: A Propensity Matched Study.

RNA-Mediated Reprogramming of Primary Adult Human Dermal Fibroblasts into c-kit(+) Cardiac Progenitor Cells.

Elevated Cardiac Troponin I in Preservation Solution Is Associated With Primary Graft Dysfunction.

Genome-wide association study of new-onset atrial fibrillation after coronary artery bypass grafting surgery.

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.

A team-based approach to patients in cardiogenic shock.

Cardiac transplantation for older patients: Characteristics and outcomes in the septuagenarian population.

Resection of Carcinoid Tumor Metastatic to the Right Ventricle and Tricuspid Valve.

Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow?

Assessing Consequences of Intraaortic Balloon Counterpulsation Versus Left Ventricular Assist Devices at the Time of Heart Transplantation.

Early Experience with a Novel Cannulation Strategy for Left Ventricular Decompression during Nonpostcardiotomy Venoarterial ECMO.

Surgical Technique for Replacement of Centrifugal Left Ventricular Assist Device Through a Left Thoracotomy.

Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.

Point-of-Care Rapid-Seeding Ventricular Assist Device with Blood-Derived Endothelial Cells to Create a Living Antithrombotic Coating.

The Diagnostic Yield of Repeated Endoscopic Evaluation in Patients with Gastrointestinal Bleeding and Left Ventricular Assist Devices.

Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States.

Gene signatures of postoperative atrial fibrillation in atrial tissue after coronary artery bypass grafting surgery in patients receiving β-blockers.

Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.

Getting to a Man's Heart through His Colon.

Pulmonary Hypertension in the Era of Mechanical Circulatory Support.

Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices.

Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality.

Thyroid hormone use during cardiac transplant organ procurement.

Concomitant Thoracic Aortobifemoral Bypass With Left Ventricular Assist Device Implantation.

A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.

Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation.

Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure.

Assessment of cardiac allograft systolic function by global longitudinal strain: From donor to recipient.

Plasma Levels of MicroRNA-155 Are Upregulated with Long-Term Left Ventricular Assist Device Support.

Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.

Elevated donor hemoglobin A1c does not impair early survival in cardiac transplant recipients.

A tale of two centrifugal left ventricular assist devices.

Usefulness of 2 centrifugal ventricular assist devices in a total artificial heart configuration: A preliminary report.

Central Cannulation as a Viable Alternative to Peripheral Cannulation in Extracorporeal Membrane Oxygenation.

Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: A systematic review and meta-analysis.

Is there a role for upper-extremity intra-aortic balloon counterpulsation as a bridge-to-recovery or a bridge-to-transplant in the treatment of end-stage heart failure?

ECMO: 40 Years Later.

Heartmate III Replacement for Recurring Left Ventricular Assist Device Pump Thrombosis.

Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors.

Biventricular Support With Intracorporeal, Continuous Flow, Centrifugal Ventricular Assist Devices.

Using a Regent Aortic Valve in a Small Annulus Mitral Position Is a Viable Option.

Migration of Intraaortic Balloon Pump Placed Via the Axillary Artery.

Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry.

Indications for and outcomes of therapeutic plasma exchange after cardiac transplantation: A single center retrospective study.

Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.

S-Nitrosylation of β-Arrestins Biases Receptor Signaling and Confers Ligand Independence.

Trends and outcomes of cardiac transplantation from donors dying of drug intoxication.

Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.

Cangrelor use prior to left ventricular assist device surgery: a case series.

HVAD: The ENDURANCE Supplemental Trial.

Successful aneurysm resection and coronary artery revascularization following saphenous vein graft aneurysm rupture.

Longitudinal Changes in Regional Cerebral Perfusion and Cognition After Cardiac Operation.

Transplanting a heart with a persistent left superior vena cava.

Is it Time to Get More Aggressive With Aortic Valve Insufficiency During LVAD Implantation?

Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery.

Coronary artery arteriovenous malformation.

Tricuspid Valve Regurgitation Immediately After Heart Transplant and Long-Term Outcomes.

LVAD Outflow Graft Role in Pump Thrombosis.

Interhospital ECMO Transport: Regional Focus.

A One-Step Autotransplantation Can Facilitate the Excision of Cardiac Tumors Invading the Lung.

Controlling axillary intra-aortic balloon pump inflation is a viable option for turning an acute heart failure patient into a chronic one.

Prothrombin Complex Concentrate Use in Durable and Short-Term Left Ventricular Assist Device Implantation.

A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.

Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial.

The HeartMate 6.

Clinical Experience of HeartMate II to HeartWare Left Ventricular Assist Device Exchange: A Multicenter Experience.

A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy.

Heart Transplantation After HeartMate 3 Use Shortens Hospitalization but Might Impose Increased Risk of Rejection.

Heart Transplantation Survival and the Use of Traumatically Brain-Injured Donors: UNOS Registry Propensity-Matched Analysis.

Constrictive Pericarditis After Lung Transplantation.

Percutaneous Intervention for Left Ventricular Assist Device Outflow Obstruction.

Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.

Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices.

Durability and Efficacy of Tricuspid Valve Repair in Patients Undergoing Left Ventricular Assist Device Implantation.

American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support.

American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support.

Increased Calculated Panel Reactive Antigen Is Associated With Increased Waitlist Time and Mortality in Lung Transplantation.

Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.

Association between primary graft dysfunction and acute kidney injury after orthotopic heart transplantation - a retrospective, observational cohort study.

Mustard Baffle Revision With Systemic Ventricular Assist Device Placement.

Stellate Ganglion Blockade for the Treatment of Refractory Ventricular Arrhythmias.

Lead Extraction for Cardiovascular Implantable Electronic Device Infection in Patients With Left Ventricular Assist Devices.

Arterial and venous thrombosis complicating coronary artery bypass grafting after use of epoetin alfa-epbx.

Use of an inverted On-X mitral valve in the aortic position in a resource limited setting.

Cardiac computed tomography improves the identification of cardiomechanical complications among patients with suspected left ventricular assist device malfunction.

Mitigating the Impact of Using Female Donor Hearts in Male Recipients Using BMI Difference.

Heart Transplantation Survival Outcomes of HIV Positive and Negative Recipients.

Cardiovascular Implantable Electronic Device Surgery Following Left Ventricular Assist Device Implantation.

Commentary: Managing the native heart in patients supported with durable left ventricular assist devices.

Conventional Ultrafiltration During Elective Cardiac Surgery and Postoperative Acute Kidney Injury.

Characteristics of strokes associated with centrifugal flow left ventricular assist devices.

OptiVol for Volume Assessment in Patients With Continuous Flow Left Ventricular Assist Device.

Electrical storm in patients with left ventricular assist devices: Risk factors, incidence, and impact on survival.

The Impact of Adverse Events on Functional Capacity and Quality of Life After HeartWare Ventricular Assist Device Implantation.

A Case of Rare Inherited Restrictive Cardiomyopathy With Severe Biatrial Enlargement.

A Case for Re-Gifting.

Temporary left ventricular assist device may be safer than veno-arterial extracorporeal membrane oxygenation for treating shock in the presence of a mitral prosthesis.

Incidence and Diagnostic Challenges of Bowel Ischemia after Continuous-flow Left Ventricular Assist Device Therapy.

Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation.

Time in Therapeutic Range Significantly Impacts Survival and Adverse Events in Destination Therapy Patients.

CARMAT Total Artificial Heart and the Quest to Improve Biventricular Mechanical Support.

Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study.

What If the Destination Is Transplant? Outcomes of Destination Therapy Patients Who Were Transplanted.